Earnings
IBRX
16.74
+4.56%
0.73
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
11.44M
54.77M
--
--
--
--
518.00K
--
--
--
7.30M
1.47M
75.50M
67.39M
--
7.85M
--
--
--
--
1.12M
76.36M
151.86M
--
4.10M
0.00
--
--
--
--
--
13.84M
--
--
--
6.71M
24.65M
0.00
--
--
--
9.81M
9.81M
34.47M
11.00K
872.08M
-754.57M
--
--
--
117.39M
117.39M
151.86M
FY 2019-12-31
15.51M
36.14M
--
--
--
--
303.00K
--
--
--
3.02M
781.00K
55.76M
72.23M
--
10.75M
--
--
0.00
--
4.39M
87.37M
143.12M
--
1.75M
0.00
--
--
--
--
--
8.55M
--
--
--
504.00K
11.56M
0.00
--
--
--
10.88M
10.88M
22.44M
10.00K
782.97M
-662.19M
--
--
--
120.68M
120.68M
143.12M
FY 2018-12-31
16.82M
58.05M
--
--
--
--
11.45M
--
--
--
2.07M
381.00K
88.77M
76.89M
--
14.20M
--
--
565.00K
--
1.53M
93.18M
181.95M
--
2.79M
0.00
--
--
--
--
--
21.10M
--
--
--
2.40M
27.26M
5.95M
--
--
0.00
2.74M
8.68M
35.94M
8000.00
741.25M
-594.98M
--
--
--
146.01M
146.01M
181.95M
FY 2017-12-31
23.87M
104.28M
--
--
--
--
1.26M
--
210.00K
--
2.17M
880.00K
132.46M
76.73M
--
38.10M
--
--
2.83M
--
330.00K
117.98M
250.44M
--
5.87M
0.00
--
--
--
--
--
11.27M
--
--
--
3.45M
20.87M
1.74M
--
--
498.00K
8.49M
10.73M
31.60M
8000.00
717.93M
-498.71M
--
--
--
218.84M
218.84M
250.44M
FY 2016-12-31
8.08M
190.84M
--
2.67M
--
--
2.67M
--
--
--
2.89M
662.00K
205.15M
19.38M
--
87.57M
--
--
5.09M
--
316.00K
112.35M
317.50M
--
4.04M
0.00
--
--
--
--
--
5.86M
--
--
--
2.64M
12.55M
2.02M
--
--
996.00K
8.50M
11.53M
24.08M
8000.00
680.76M
-387.06M
--
--
--
293.42M
293.42M
317.50M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out IBRX latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze ImmunityBio Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.